PURPOSE OF REVIEW: To determine that GreenLight laser therapy is now an established treatment option for men with lower urinary tract symptoms (LUTS) associated with benign prostatic enlargement (BPE). RECENT FINDINGS: The three generations of the GreenLight laser, 80, 120 and 180 W, have been studied for efficacy and safety in the treatment of men with LUTS associated with BPE. Studies have also been conducted that compare outcome with transurethral resection of the prostate, historically considered the gold-standard treatment for this patient group. SUMMARY: GreenLight is an established therapeutic option for LUTS associated with BPE. It can be used safely and effectively in men on anticoagulants, in retention and with prostates of size greater than 80 ml. The safety and efficacy of this treatment are comparable to transurethral resection of the prostate.
PURPOSE OF REVIEW: To determine that GreenLight laser therapy is now an established treatment option for men with lower urinary tract symptoms (LUTS) associated with benign prostatic enlargement (BPE). RECENT FINDINGS: The three generations of the GreenLight laser, 80, 120 and 180 W, have been studied for efficacy and safety in the treatment of men with LUTS associated with BPE. Studies have also been conducted that compare outcome with transurethral resection of the prostate, historically considered the gold-standard treatment for this patient group. SUMMARY: GreenLight is an established therapeutic option for LUTS associated with BPE. It can be used safely and effectively in men on anticoagulants, in retention and with prostates of size greater than 80 ml. The safety and efficacy of this treatment are comparable to transurethral resection of the prostate.
Authors: Luca Cindolo; Lorenzo Ruggera; Paolo Destefanis; Claudio Dadone; Giovanni Ferrari Journal: Int Urol Nephrol Date: 2017-01-02 Impact factor: 2.370